Find in Library

1189 Elucidating the effects of chemotherapy and immune checkpoint blockade on the activity of tarlatamab, a DLL3-targeting bispecific T cell engager molecule, in small cell lung cancer preclinical models

oleh: Keegan Cooke, Jinghui Zhan, Juan Estrada, Matthias Friedrich, Ran You, Petra Deegen, Julie M Bailis